27 results on '"Bi W. L."'
Search Results
2. Abiotic stress improves in vitro biological indexing of Grapevine leafroll-associated virus-3 in red grapevine cultivars
- Author
-
Cui, Z.-H., Bi, W.-L., Pan, C., Xu, Y., and Wang, Q.-C.
- Published
- 2015
- Full Text
- View/download PDF
3. Molecular and translational advances in meningiomas
- Author
-
Suppiah S., Nassiri F., Bi W. L., Dunn I. F., Hanemann C. O., Horbinski C. M., Hashizume R., James C. D., Mawrin C., Noushmehr H., Perry A., Sahm F., Sloan A., Von Deimling A., Wen P. Y., Aldape K., Zadeh G., Au K., Barnhartz-Sloan J., Brastianos P. K., Butowski N., Carlotti C., Cusimano M. D., Dimeco F., Drummond K., Galanis E., Giannini C., Goldbrunner R., Griffith B., Herold-Mende C., Huang R. Y., James D., Jenkinson M. D., Jungk C., Kaufman T. J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J. C., Mamatjan Y., Mansouri A., McDermott M., Munoz D., Ng H. -K., Pirouzmand F., Poisson L. M., Pollo B., Raleigh D., Saladino A., Santarius T., Schichor C., Schultz D., Schmidt N. O., Selman W., Spears J., Snyder J., Tabatabai G., Tatagiba M., Tirapelli D., Tonn J. C., Tsang D., Vogelbaum M. A., Deimling A. V., Walbert T., Westphal M., Workewych A. M., Suppiah S., Nassiri F., Bi W.L., Dunn I.F., Hanemann C.O., Horbinski C.M., Hashizume R., James C.D., Mawrin C., Noushmehr H., Perry A., Sahm F., Sloan A., Von Deimling A., Wen P.Y., Aldape K., Zadeh G., Au K., Barnhartz-Sloan J., Brastianos P.K., Butowski N., Carlotti C., Cusimano M.D., Dimeco F., Drummond K., Galanis E., Giannini C., Goldbrunner R., Griffith B., Herold-Mende C., Huang R.Y., James D., Jenkinson M.D., Jungk C., Kaufman T.J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J.C., Mamatjan Y., Mansouri A., McDermott M., Munoz D., Ng H.-K., Pirouzmand F., Poisson L.M., Pollo B., Raleigh D., Saladino A., Santarius T., Schichor C., Schultz D., Schmidt N.O., Selman W., Spears J., Snyder J., Tabatabai G., Tatagiba M., Tirapelli D., Tonn J.C., Tsang D., Vogelbaum M.A., Deimling A.V., Walbert T., Westphal M., and Workewych A.M.
- Subjects
Cancer Research ,Supplement Articles ,Genomics ,Intracranial Neoplasm ,sporadic meningioma ,Bioinformatics ,World health ,Translational Research, Biomedical ,Meningioma ,03 medical and health sciences ,biomolecular ,0302 clinical medicine ,Meningeal Neoplasms ,otorhinolaryngologic diseases ,medicine ,Recurrent disease ,Humans ,Meningeal Neoplasm ,Molecular Targeted Therapy ,xenograft ,Stage (cooking) ,neoplasms ,MENINGIOMA ,business.industry ,cell line ,Prognosis ,medicine.disease ,Combined Modality Therapy ,nervous system diseases ,3. Good health ,Clinical trial ,Oncology ,030220 oncology & carcinogenesis ,Neurology (clinical) ,genetic ,business ,epigenetic ,030217 neurology & neurosurgery - Abstract
Meningiomas are the most common primary intracranial neoplasm. The current World Health Organization (WHO) classification categorizes meningiomas based on histopathological features, but emerging molecular data demonstrate the importance of genomic and epigenomic factors in the clinical behavior of these tumors. Treatment options for symptomatic meningiomas are limited to surgical resection where possible and adjuvant radiation therapy for tumors with concerning histopathological features or recurrent disease. At present, alternative adjuvant treatment options are not available in part due to limited historical biological analysis and clinical trial investigation on meningiomas. With advances in molecular and genomic techniques in the last decade, we have witnessed a surge of interest in understanding the genomic and epigenomic landscape of meningiomas. The field is now at the stage to adopt this molecular knowledge to refine meningioma classification and introduce molecular algorithms that can guide prediction and therapeutics for this tumor type. Animal models that recapitulate meningiomas faithfully are in critical need to test new therapeutics to facilitate rapid-cycle translation to clinical trials. Here we review the most up-to-date knowledge of molecular alterations that provide insight into meningioma behavior and are ready for application to clinical trial investigation, and highlight the landscape of available preclinical models in meningiomas.
- Published
- 2019
- Full Text
- View/download PDF
4. Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life
- Author
-
Nassiri F., Price B., Shehab A., Au K., Cusimano M. D., Jenkinson M. D., Jungk C., Mansouri A., Santarius T., Suppiah S., Teng K. X., Toor G. S., Zadeh G., Walbert T., Drummond K. J., Aldape K., Barnhartz-Sloan J., Bi W. L., Brastianos P. K., Butowski N., Carlotti C., Dimeco F., Dunn I. F., Galanis E., Giannini C., Goldbrunner R., Griffith B., Hashizume R., Hanemann C. O., Herold-Mende C., Horbinski C., Huang R. Y., James D., Kaufman T. J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J. C., Mamatjan Y., Mawrin C., McDermott M., Munoz D., Noushmehr H., Ng H. -K., Perry A., Pirouzmand F., Poisson L. M., Pollo B., Raleigh D., Sahm F., Saladino A., Schichor C., Schultz D., Schmidt N. O., Selman W., Sloan A., Spears J., Snyder J., Tabatabai G., Tatagiba M., Tirapelli D., Tonn J. C., Tsang D., Vogelbaum M. A., Deimling A. V., Wen P. Y., Westphal M., Workewych A. M., Nassiri F., Price B., Shehab A., Au K., Cusimano M.D., Jenkinson M.D., Jungk C., Mansouri A., Santarius T., Suppiah S., Teng K.X., Toor G.S., Zadeh G., Walbert T., Drummond K.J., Aldape K., Barnhartz-Sloan J., Bi W.L., Brastianos P.K., Butowski N., Carlotti C., Dimeco F., Dunn I.F., Galanis E., Giannini C., Goldbrunner R., Griffith B., Hashizume R., Hanemann C.O., Herold-Mende C., Horbinski C., Huang R.Y., James D., Kaufman T.J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J.C., Mamatjan Y., Mawrin C., McDermott M., Munoz D., Noushmehr H., Ng H.-K., Perry A., Pirouzmand F., Poisson L.M., Pollo B., Raleigh D., Sahm F., Saladino A., Schichor C., Schultz D., Schmidt N.O., Selman W., Sloan A., Spears J., Snyder J., Tabatabai G., Tatagiba M., Tirapelli D., Tonn J.C., Tsang D., Vogelbaum M.A., Deimling A.V., Wen P.Y., Westphal M., and Workewych A.M.
- Subjects
Male ,cognition ,Cancer Research ,medicine.medical_specialty ,Cross-sectional study ,insomnia ,Population ,Neurosurgery ,Supplement Articles ,meningioma ,surgery ,Meningioma ,03 medical and health sciences ,0302 clinical medicine ,Quality of life ,Surveys and Questionnaires ,Internal medicine ,Meningeal Neoplasms ,otorhinolaryngologic diseases ,medicine ,Humans ,Longitudinal Studies ,Prospective Studies ,Prospective cohort study ,education ,education.field_of_study ,business.industry ,COGNIÇÃO ,Cognition ,Middle Aged ,Prognosis ,medicine.disease ,humanities ,3. Good health ,health-related quality of life ,Cross-Sectional Studies ,Oncology ,030220 oncology & carcinogenesis ,Quality of Life ,Female ,fatigue ,Neurology (clinical) ,business ,030217 neurology & neurosurgery ,Follow-Up Studies ,Cohort study - Abstract
Background Few studies have evaluated the health-related quality of life (HRQoL) of patients with meningiomas. Here, we report the largest prospective, longitudinal cross-sectional cohort study of HRQoL in meningiomas to date, in order to identify possible actionable determinants of global HRQoL. Methods Adults who had undergone resection of a grade I intracranial meningioma and were in routine follow-up at a single large tertiary center underwent HRQoL assessment using the QLQ-C30 questionnaire administered opportunistically at follow-up visits. Averaged transformed QLQ-C30 scores at 12-month intervals were compared with scores from a normative reference population, with reference to known minimal clinically meaningful difference (CMD) in scores. To evaluate for possible determinants of changes in global HRQoL, global HRQoL scores were correlated (Spearman's Rho) with subdomain and symptom scores and with interval time from surgical resection. Results A total of 291 postoperative patients with histologically confirmed and surgically treated grade I meningiomas consented to participation and a total of 455 questionnaires were included for analysis. Patients with meningiomas reported reduced global HRQoL at nearly every 12-month interval with clinically and statistically significant impairments at 12, 48, 108, and 120 months postoperative compared with the normative population (P < 0.05). Meningioma patients at the 12-month interval also reported a reduction of each subdomain of HRQoL assessment (P < 0.05); however, a CMD was only seen in cognitive functioning. Physical, emotional, cognitive, and social subdomains, as well as fatigue and sleep/insomnia, were significantly associated with global HRQoL at the first 12-month interval. Overall, there was no significant correlation between time from surgery and global HRQoL or the subdomain functional or symptom sections of the QLQ-C30. Conclusions Meningioma patients report considerable limitations in HRQoL for more than 120 months after surgery, particularly in cognitive, emotional, and social function, as well as suffering significant fatigue and sleep impairment compared with a normative reference population. The majority of these reported functional impairments and symptoms are strongly associated with global HRQoL and thus can be considered determinants of global HRQoL that if treated, have the potential to improve HRQoL for our meningioma patients. This hypothesis requires future study of targeted interventions to determine their efficacy.
- Published
- 2019
- Full Text
- View/download PDF
5. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management
- Author
-
Nassiri F., Mamatjan Y., Suppiah S., Badhiwala J. H., Mansouri S., Karimi S., Saarela O., Poisson L., Gepfner-Tuma I., Schittenhelm J., Ng H. -K., Noushmehr H., Harter P., Baumgarten P., Weller M., Preusser M., Herold-Mende C., Tatagiba M., Tabatabai G., Sahm F., Von Deimling A., Aldape K., Au K., Barnhartz-Sloan J., Bi W. L., Brastianos P. K., Butowski N., Carlotti C., Cusimano M. D., Dimeco F., Drummond K., Dunn I. F., Galanis E., Giannini C., Goldbrunner R., Griffith B., Hashizume R., Hanemann C. O., Horbinski C., Huang R. Y., James D., Jenkinson M. D., Jungk C., Kaufman T. J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J. C., Malta T. M., Mawrin C., McDermott M., Munoz D., Perry A., Pirouzmand F., Poisson L. M., Pollo B., Raleigh D., Saladino A., Santarius T., Schichor C., Schultz D., Schmidt N. O., Selman W., Sloan A., Spears J., Snyder J., Tirapelli D., Tonn J. C., Tsang D., Vogelbaum M. A., Wen P. Y., Walbert T., Westphal M., Workewych A. M., Zadeh G., Aldape K. D., Nassiri F., Mamatjan Y., Suppiah S., Badhiwala J.H., Mansouri S., Karimi S., Saarela O., Poisson L., Gepfner-Tuma I., Schittenhelm J., Ng H.-K., Noushmehr H., Harter P., Baumgarten P., Weller M., Preusser M., Herold-Mende C., Tatagiba M., Tabatabai G., Sahm F., Von Deimling A., Aldape K., Au K., Barnhartz-Sloan J., Bi W.L., Brastianos P.K., Butowski N., Carlotti C., Cusimano M.D., Dimeco F., Drummond K., Dunn I.F., Galanis E., Giannini C., Goldbrunner R., Griffith B., Hashizume R., Hanemann C.O., Horbinski C., Huang R.Y., James D., Jenkinson M.D., Jungk C., Kaufman T.J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J.C., Malta T.M., Mawrin C., McDermott M., Munoz D., Perry A., Pirouzmand F., Poisson L.M., Pollo B., Raleigh D., Saladino A., Santarius T., Schichor C., Schultz D., Schmidt N.O., Selman W., Sloan A., Spears J., Snyder J., Tirapelli D., Tonn J.C., Tsang D., Vogelbaum M.A., Wen P.Y., Walbert T., Westphal M., Workewych A.M., Zadeh G., and Aldape K.D.
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,recurrence ,predictor ,ESTUDOS DE VALIDAÇÃO ,Meningioma ,nomogram ,Internal medicine ,medicine ,Biomarkers, Tumor ,Meningeal Neoplasms ,Humans ,Survival rate ,Retrospective Studies ,Oncotype DX Breast Cancer Assay ,business.industry ,Hazard ratio ,Cancer ,Disease Management ,Retrospective cohort study ,Nomogram ,DNA Methylation ,medicine.disease ,Prognosis ,Gene Expression Regulation, Neoplastic ,Survival Rate ,Clinical research ,Basic and Translational Investigations ,Neurology (clinical) ,methylation ,Neoplasm Recurrence, Local ,business ,Follow-Up Studies - Abstract
Background Variability in standard-of-care classifications precludes accurate predictions of early tumor recurrence for individual patients with meningioma, limiting the appropriate selection of patients who would benefit from adjuvant radiotherapy to delay recurrence. We aimed to develop an individualized prediction model of early recurrence risk combining clinical and molecular factors in meningioma. Methods DNA methylation profiles of clinically annotated tumor samples across multiple institutions were used to develop a methylome model of 5-year recurrence-free survival (RFS). Subsequently, a 5-year meningioma recurrence score was generated using a nomogram that integrated the methylome model with established prognostic clinical factors. Performance of both models was evaluated and compared with standard-of-care models using multiple independent cohorts. Results The methylome-based predictor of 5-year RFS performed favorably compared with a grade-based predictor when tested using the 3 validation cohorts (ΔAUC = 0.10, 95% CI: 0.03–0.018) and was independently associated with RFS after adjusting for histopathologic grade, extent of resection, and burden of copy number alterations (hazard ratio 3.6, 95% CI: 1.8–7.2, P < 0.001). A nomogram combining the methylome predictor with clinical factors demonstrated greater discrimination than a nomogram using clinical factors alone in 2 independent validation cohorts (ΔAUC = 0.25, 95% CI: 0.22–0.27) and resulted in 2 groups with distinct recurrence patterns (hazard ratio 7.7, 95% CI: 5.3–11.1, P < 0.001) with clinical implications. Conclusions The models developed and validated in this study provide important prognostic information not captured by previously established clinical and molecular factors which could be used to individualize decisions regarding postoperative therapeutic interventions, in particular whether to treat patients with adjuvant radiotherapy versus observation alone.
- Published
- 2019
6. Advances in multidisciplinary therapy for meningiomas
- Author
-
Brastianos P. K., Galanis E., Butowski N., Chan J. W., Dunn I. F., Goldbrunner R., Herold-Mende C., Ippen F. M., Mawrin C., McDermott M. W., Sloan A., Snyder J., Tabatabai G., Tatagiba M., Tonn J. C., Wen P. Y., Aldape K., Nassiri F., Zadeh G., Jenkinson M. D., Raleigh D. R., Au K., Barnhartz-Sloan J., Bi W. L., Carlotti C., Cusimano M. D., Dimeco F., Drummond K., Giannini C., Griffith B., Hashizume R., Hanemann C. O., Horbinski C., Huang R. Y., James D., Jungk C., Kaufman T. J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J. C., Mamatjan Y., Mansouri A., Munoz D., Noushmehr H., Ng H. -K., Perry A., Pirouzmand F., Poisson L. M., Pollo B., Sahm F., Saladino A., Santarius T., Schichor C., Schultz D., Schmidt N. O., Selman W., Spears J., Suppiah S., Tirapelli D., Tsang D., Vogelbaum M. A., Deimling A. V., Walbert T., Westphal M., Workewych A. M., Brastianos P.K., Galanis E., Butowski N., Chan J.W., Dunn I.F., Goldbrunner R., Herold-Mende C., Ippen F.M., Mawrin C., McDermott M.W., Sloan A., Snyder J., Tabatabai G., Tatagiba M., Tonn J.C., Wen P.Y., Aldape K., Nassiri F., Zadeh G., Jenkinson M.D., Raleigh D.R., Au K., Barnhartz-Sloan J., Bi W.L., Carlotti C., Cusimano M.D., Dimeco F., Drummond K., Giannini C., Griffith B., Hashizume R., Hanemann C.O., Horbinski C., Huang R.Y., James D., Jungk C., Kaufman T.J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J.C., Mamatjan Y., Mansouri A., Munoz D., Noushmehr H., Ng H.-K., Perry A., Pirouzmand F., Poisson L.M., Pollo B., Sahm F., Saladino A., Santarius T., Schichor C., Schultz D., Schmidt N.O., Selman W., Spears J., Suppiah S., Tirapelli D., Tsang D., Vogelbaum M.A., Deimling A.V., Walbert T., Westphal M., and Workewych A.M.
- Subjects
Oncology ,Cancer Research ,medicine.medical_treatment ,Supplement Articles ,meningioma ,Systemic therapy ,surgery ,0302 clinical medicine ,Meningeal Neoplasms ,Trabectedin ,Cancer ,clinical trial ,targeted therapy ,Prognosis ,Combined Modality Therapy ,3. Good health ,6.1 Pharmaceuticals ,030220 oncology & carcinogenesis ,International Consortium on Meningiomas ,Patient Safety ,Meningioma ,medicine.drug ,medicine.medical_specialty ,Oncology and Carcinogenesis ,Antineoplastic Agents ,Radiosurgery ,03 medical and health sciences ,Internal medicine ,medicine ,otorhinolaryngologic diseases ,Humans ,Meningeal Neoplasm ,Oncology & Carcinogenesis ,neoplasms ,business.industry ,Neurosciences ,Evaluation of treatments and therapeutic interventions ,medicine.disease ,RADIOTERAPIA ,Brain Disorders ,nervous system diseases ,Clinical trial ,Radiation therapy ,radiation ,Neurology (clinical) ,Cranial Irradiation ,business ,030217 neurology & neurosurgery - Abstract
Surgery has long been established as the first-line treatment for the majority of symptomatic and enlarging meningiomas, and evidence for its success is derived from retrospective case series. Despite surgical resection, a subset of meningiomas display aggressive behavior with early recurrences that are difficult to treat. The decision to radically resect meningiomas and involved structures is balanced against the risk for neurological injury in patients. Radiation therapy has largely been used as a complementary and safe therapeutic strategy in meningiomas with evidence primarily stemming from retrospective, single-institution reports. Two of the first cooperative group studies (RTOG 0539 and EORTC 22042) evaluating the outcomes of adjuvant radiation therapy in higher-risk meningiomas have shown promising preliminary results. Historically, systemic therapy has resulted in disappointing results in meningiomas. However, several clinical trials are under way evaluating the efficacy of chemotherapies, such as trabectedin, and novel molecular agents targeting Smoothened, AKT1, and focal adhesion kinase in patients with recurrent meningiomas.
- Published
- 2019
7. Imaging and diagnostic advances for intracranial meningiomas
- Author
-
Huang R. Y., Bi W. L., Griffith B., Kaufmann T. J., La Fougere C., Schmidt N. O., Tonn J. C., Vogelbaum M. A., Wen P. Y., Aldape K., Nassiri F., Zadeh G., Dunn I. F., Au K., Barnhartz-Sloan J., Brastianos P. K., Butowski N., Carlotti C., Cusimano M. D., Dimeco F., Drummond K., Galanis E., Giannini C., Goldbrunner R., Hashizume R., Hanemann C. O., Herold-Mende C., Horbinski C., James D., Jenkinson M. D., Jungk C., Kaufman T. J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J. C., Mamatjan Y., Mansouri A., Mawrin C., McDermott M., Munoz D., Noushmehr H., Ng H. -K., Perry A., Pirouzmand F., Poisson L. M., Pollo B., Raleigh D., Sahm F., Saladino A., Santarius T., Schichor C., Schultz D., Selman W., Sloan A., Spears J., Snyder J., Suppiah S., Tabatabai G., Tatagiba M., Tirapelli D., Tsang D., Deimling A. V., Walbert T., Westphal M., Workewych A. M., Huang R.Y., Bi W.L., Griffith B., Kaufmann T.J., La Fougere C., Schmidt N.O., Tonn J.C., Vogelbaum M.A., Wen P.Y., Aldape K., Nassiri F., Zadeh G., Dunn I.F., Au K., Barnhartz-Sloan J., Brastianos P.K., Butowski N., Carlotti C., Cusimano M.D., Dimeco F., Drummond K., Galanis E., Giannini C., Goldbrunner R., Hashizume R., Hanemann C.O., Herold-Mende C., Horbinski C., James D., Jenkinson M.D., Jungk C., Kaufman T.J., Krischek B., Lachance D., Lafougere C., Lee I., Liu J.C., Mamatjan Y., Mansouri A., Mawrin C., McDermott M., Munoz D., Noushmehr H., Ng H.-K., Perry A., Pirouzmand F., Poisson L.M., Pollo B., Raleigh D., Sahm F., Saladino A., Santarius T., Schichor C., Schultz D., Selman W., Sloan A., Spears J., Snyder J., Suppiah S., Tabatabai G., Tatagiba M., Tirapelli D., Tsang D., Deimling A.V., Walbert T., Westphal M., and Workewych A.M.
- Subjects
Cancer Research ,medicine.medical_specialty ,Neuroimaging ,Supplement Articles ,Multimodal Imaging ,perfusion ,Meningioma ,03 medical and health sciences ,0302 clinical medicine ,Medical imaging ,medicine ,Meningeal Neoplasms ,Humans ,Meningeal Neoplasm ,Radiation treatment planning ,medicine.diagnostic_test ,business.industry ,imaging ,Magnetic resonance imaging ,medicine.disease ,radiology ,3. Good health ,Tumor detection ,RADIOLOGIA ,PET ,Oncology ,030220 oncology & carcinogenesis ,Radiological weapon ,Neurology (clinical) ,Radiology ,business ,030217 neurology & neurosurgery ,CT ,MRI - Abstract
The archetypal imaging characteristics of meningiomas are among the most stereotypic of all central nervous system (CNS) tumors. In the era of plain film and ventriculography, imaging was only performed if a mass was suspected, and their results were more suggestive than definitive. Following more than a century of technological development, we can now rely on imaging to non-invasively diagnose meningioma with great confidence and precisely delineate the locations of these tumors relative to their surrounding structures to inform treatment planning. Asymptomatic meningiomas may be identified and their growth monitored over time; moreover, imaging routinely serves as an essential tool to survey tumor burden at various stages during the course of treatment, thereby providing guidance on their effectiveness or the need for further intervention. Modern radiological techniques are expanding the power of imaging from tumor detection and monitoring to include extraction of biologic information from advanced analysis of radiological parameters. These contemporary approaches have led to promising attempts to predict tumor grade and, in turn, contribute prognostic data. In this supplement article, we review important current and future aspects of imaging in the diagnosis and management of meningioma, including conventional and advanced imaging techniques using CT, MRI, and nuclear medicine.
- Published
- 2019
8. Cryopreservation of small leaf squares-bearing adventitious buds of Lilium oriental hybrid 'Siberia' by vitrification
- Author
-
Pan, C., Liu, J., Bi, W. L., Chen, H. Y., Engelmann, Florent, and Wang, Q. C.
- Subjects
Cryopreservation ,Adventitious buds ,Lilium ,Leaf segments ,Vitrification - Abstract
We report a new cryopreservation method for Lilium Oriental hybrid 'Siberia'. Adventitious buds were induced from leaf segments cultured for 12 days on adventitious bud induction medium composed of half-strength Murashige and Skoog medium (MS) supplemented with 1 mg L-1 alpha-naphthalene acetic acid and 0.5 mg L-1 thidiazuron. Small leaf squares (SLSs, 3 x 4 mm), each bearing at least one adventitious bud, were cut from leaf segments, precultured on medium with 0.5 M sucrose for 1 day, and then treated for 20 min with a loading solution containing 0.4 M sucrose and 2 M glycerol, followed by exposure to plant vitrification solution 2 for 7 h at 0 A degrees C. Dehydrated SLSs were directly immersed in liquid nitrogen for 1 h. Cryopreserved SLSs were re-warmed in MS medium containing 1.2 M sucrose for 20 min at room temperature, followed by post-thaw culture for recovery. With this procedure, 85% survival and 72% shoot regrowth were achieved following cryopreservation. The use of SLSs bearing adventitious buds for cryopreservation reported in the present study eliminates the time-consuming and labour-intensive step of shoot tip excision, and has great potential to facilitate cryopreservation in other plant species.
- Published
- 2018
9. OS10.1 Genomic landscape of pituitary adenomas
- Author
-
Bi, W. L., primary, Greenwald, N. F., additional, Abedalthagafi, M., additional, Horowitz, P., additional, Laws, E. R., additional, Beroukhim, R., additional, and Dunn, I. F., additional
- Published
- 2017
- Full Text
- View/download PDF
10. OS08.3 Genomic landscape of meningiomas
- Author
-
Bi, W. L., primary, Greenwald, N. F., additional, Abedalthagafi, M., additional, Agarwalla, P., additional, Horowitz, P., additional, Santagata, S., additional, Al-Mefty, O., additional, Beroukhim, R., additional, and Dunn, I. F., additional
- Published
- 2017
- Full Text
- View/download PDF
11. Development, histological observations andGrapevine leafroll-associated virus-3localisation inin vitrograpevine micrografts
- Author
-
Hao, X.-Y., primary, Bi, W.-L., additional, Cui, Z.-H., additional, Pan, C., additional, Xu, Y., additional, and Wang, Q.-C., additional
- Published
- 2017
- Full Text
- View/download PDF
12. Abiotic stress improves in vitro biological indexing ofGrapevine leafroll-associated virus-3in red grapevine cultivars
- Author
-
Cui, Z.-H., primary, Bi, W.-L., additional, Pan, C., additional, Xu, Y., additional, and Wang, Q.-C., additional
- Published
- 2015
- Full Text
- View/download PDF
13. PLANT PATHOGEN ERADICATION BY CRYOTHERAPY OF SHOOT TIPS: DEVELOPMENT, ACHIEVEMENTS AND PROSPECTIVE
- Author
-
Cui, Z.-H., primary, Li, B.-Q., additional, Bi, W.-L., additional, Li, J.-W., additional, and Wang, Q.-C., additional
- Published
- 2015
- Full Text
- View/download PDF
14. Development, histological observations and Grapevine leafroll-associated virus-3 localisation in in vitro grapevine micrografts.
- Author
-
Hao, X.‐Y., Bi, W.‐L., Cui, Z.‐H., Pan, C., Xu, Y., and Wang, Q.‐C.
- Subjects
- *
GRAPEVINE leafroll virus , *GRAFTING (Horticulture) , *PLANT development , *PLANT histology , *PLANT shoots - Abstract
Development, histological process and Grapevine leafroll-associated virus-3 localisation were studied in micrografts of three scion/rootstock combinations: healthy/healthy, healthy/infected and infected/healthy. Earlier bud break and faster growth in scions of micrografts were obtained when the healthy shoot segments were used as scions, while earlier bud break in rootstocks and greater fresh weight of roots in micrografts were produced when the healthy shoot segments were used as rootstocks. All histological processes including callus initiation and formation in micrografting conjunctions, and initiation of new cambial cells followed by vascular bundle development connecting scions and rootstocks were similar in micrografts, regardless of the sanitary status of the scions and rootstocks used for micrografting. Virus infection in micrografting conjunctions and systematic infection in micrografts were much more efficient and faster in micrografting combination of the infected scions/healthy rootstocks than in the healthy scions/infected rootstocks. To the best of our knowledge, this is the first report addressing histological process of micrograft development and virus localisation in micrografts. In vitro culture system established in this study facilitates studies on the 'pure' impact of the viral infection on micrografting. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
15. Plant regeneration via embryo-like structures: histological observations and genetic stability in regenerants ofLiliumspp.
- Author
-
Bi, W.-L., primary, Chen, L., additional, Guo, L., additional, Pan, C., additional, Yin, Z.-F., additional, and Wang, Q.-C., additional
- Published
- 2015
- Full Text
- View/download PDF
16. Beating the odds: extreme long-term survival with glioblastoma
- Author
-
Bi, W. L., primary and Beroukhim, R., additional
- Published
- 2014
- Full Text
- View/download PDF
17. PLANT REGENERATION AND CRYOPRESERVATION OF LILIUM
- Author
-
Yin, Z.-F., primary, Bi, W.-L., additional, Chen, L., additional, and Wang, Q.-C., additional
- Published
- 2014
- Full Text
- View/download PDF
18. Ga-Doped ZnO Grown by Atomic Layer Deposition and the Application to Blue Light-Emitting Diodes as a Current Spreading Layer
- Author
-
Bi, W.-L., primary, Ho, C.-L., additional, and Wu, M.-C., additional
- Published
- 2013
- Full Text
- View/download PDF
19. Abiotic stress improves in vitro biological indexing of G rapevine leafroll-associated virus-3 in red grapevine cultivars.
- Author
-
Cui, Z.‐H., Bi, W.‐L., Pan, C., Xu, Y., and Wang, Q.‐C.
- Subjects
- *
ABIOTIC environment , *ABIOTIC stress , *FORTIFIED wines , *CULTIVATORS , *VINEYARDS - Abstract
Background and Aims Virus detection is necessary for in vitro production and propagation of virus-free plants, for in vitro conservation and when material is received from overseas in tissue culture. In vitro biological virus indexing is among the reliable techniques. The aim of the present study was to develop an in vitro graft-free protocol for indexing of G rapevine leafroll-associated virus-3 ( GLRaV-3). Methods and Results In vitro GLRaV-3-infected shoots were cultured on half-strength Murashige and Skoog medium supplemented with either 150 mmol NaCl or 4% polyethylene glycol ( PEG) 8000 to induce development of the virus symptoms. After 4 weeks of culture, the proportion of the symptom expression was 86 and 81% for Cabernet Sauvignon, 100 for '6-12-2', 78 and 72% for Red Globe and 70 and 60% for Kyoho in the diseased shoots stressed by 150 mmol NaCl and 4% PEG, respectively. Expression of virus symptoms was more obvious and reliable when in vitro plantlets were stressed by NaCl than by PEG. Conclusions Salt and drought stress induced by NaCl and PEG 8000 can improve in vitro biological indexing of GLRaV-3 in red grapevine cultivars. Significance of the Study The techniques developed in the present study would have potential application to GLRaV-3 indexing of red grapevine cultivars. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
20. HSV-tk Gene Therapy in Head and Neck Squamous Cell Carcinoma: Enhancement by the Local and Distant Bystander Effect
- Author
-
Wilson, K. M., primary, Stambrook, P. J., additional, Bi, W. L., additional, Pavelic, Z. P., additional, Pavelic, L., additional, and Gluckman, J. L., additional
- Published
- 1996
- Full Text
- View/download PDF
21. Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas
- Author
-
Cryan, J. B., Haidar, S., Ramkissoon, L. A., Bi, W. L., David Knoff, Schultz, N., Abedalthagafi, M., Brown, L., Wen, P. Y., Reardon, D. A., Dunn, I. F., Folkerth, R. D., Santagata, S., Lindeman, N. I., Ligon, A. H., Beroukhim, R., Hornick, J. L., Alexander, B. M., Ligon, K. L., and Ramkissoon, S. H.
22. A comprehensive review of MR imaging changes following radiosurgery to 500 brain metastases.
- Author
-
Patel TR, McHugh BJ, Bi WL, Minja FJ, Knisely JP, and Chiang VL
- Subjects
- Adult, Aged, Aged, 80 and over, Connecticut epidemiology, Female, Humans, Male, Middle Aged, Prevalence, Reproducibility of Results, Risk Assessment, Risk Factors, Sensitivity and Specificity, Survival Analysis, Survival Rate, Brain Neoplasms pathology, Brain Neoplasms secondary, Brain Neoplasms surgery, Magnetic Resonance Imaging statistics & numerical data, Radiosurgery statistics & numerical data
- Abstract
Background and Purpose: Stereotactic radiosurgery is known to control 85%-95% of intracranial metastatic lesions during a median survival of 6-8 months. However, with the advent of newer systemic cancer therapies, survival is improving; this change mandates a longitudinal quantitative analysis of the radiographic response of brain metastases to radiosurgery., Materials and Methods: MR imaging of 516 metastases in 120 patients treated with GK-SRS from June 2006 to December 2009 was retrospectively reviewed. Lesion volume at initial treatment and each follow-up was calculated by using the following formula: length × width × height / 2. Volume changes were correlated with patient demographics, histopathology, and radiation treatment variables., Results: Thirty-two percent of lesions increased in volume following radiosurgery. Clinically, this translated into 54% of patients having ≥1 of their lesions increase in size. This increase begins at 6 weeks and can last beyond 15 months' post-SRS. Male sex (P = .002), mean voxel dose <37 Gy (P = .009), and initial treatment volume >500 mm(3) (P < .001) are associated with posttreatment increases in tumor size. Median survival following radiosurgery was 9.5 months for patients with all lesions exhibiting stable/decreased volumes, >18.4 months for patients with all lesions exhibiting increased volumes, and 16.4 months for patients with mixed lesional responses., Conclusions: Most metastatic lesions are stable or smaller in size during the first 36 months post-SRS. However, a transient increase in volume is seen in approximately one-third of lesions. Sex, treatment dose, initial lesion size, and histopathology all correlate with variations in lesion volume post-SRS. The longer the patient survives, the more likely an increase in lesion size will be seen on follow-up imaging.
- Published
- 2011
- Full Text
- View/download PDF
23. HSV-tk gene therapy in head and neck squamous cell carcinoma. Enhancement by the local and distant bystander effect.
- Author
-
Wilson KM, Stambrook PJ, Bi WL, Pavelic ZP, Pavelic L, and Gluckman JL
- Subjects
- 3T3 Cells, Animals, Antiviral Agents pharmacology, Carcinoma, Squamous Cell genetics, Ganciclovir pharmacology, Genes, Viral drug effects, Head and Neck Neoplasms genetics, Humans, Mice, Mice, Nude, Neoplasm Transplantation, Prospective Studies, Remission Induction, Simplexvirus drug effects, Simplexvirus enzymology, Thymidine Kinase drug effects, Tumor Cells, Cultured, Carcinoma, Squamous Cell therapy, Genes, Viral genetics, Genetic Therapy methods, Head and Neck Neoplasms therapy, Simplexvirus genetics, Thymidine Kinase genetics
- Abstract
Objectives: To determine whether the bystander effect demonstrated in vitro for ganciclovir-mediated killing of a herpes simplex virus thymidine kinase (HSV-tk) gene-infected human squamous cell carcinoma is operative in vivo in a nude mouse model., Design: Prospective study in a murine model., Intervention: Human head and neck squamous cell carcinoma tumors were grown as xenografts on the flanks of 20 nude mice. The tumors in the left flank were then infected with the HSV-tk gene. Then, after 48 hours, the animals were treated with intraperitoneal ganciclovir twice daily. Assessment of the tumors on both flanks was performed over a 31-day period., Main Outcome Measures: Resolution of tumors infected with HSV-tk gene in animals treated with ganciclovir; resolution of tumors uninfected with HSV-tk gene on the contralateral flank in animals treated with ganciclovir., Results: Following HSV-tk gene therapy in nude mice, complete resolution of HSV-tk-gene-infected human head and neck squamous cell carcinoma tumors was observed following ganciclovir treatment. Uninfected tumors were also noted to regress, but not completely resolve, in response to intraperitoneal ganciclovir (distant bystander effect)., Conclusions: This study confirms that the local and distant bystander effects exist in this murine model, enhancing the possibility of its role for treatment of human squamous cell carcinoma of the head and neck.
- Published
- 1996
- Full Text
- View/download PDF
24. Protein and messenger RNA expression of connexin43 in astrocytomas: implications in brain tumor gene therapy.
- Author
-
Shinoura N, Chen L, Wani MA, Kim YG, Larson JJ, Warnick RE, Simon M, Menon AG, Bi WL, and Stambrook PJ
- Subjects
- Blotting, Northern, Gene Expression genetics, Humans, Immunohistochemistry, Tumor Cells, Cultured, Astrocytoma drug therapy, Brain Neoplasms drug therapy, Connexin 43 genetics, Proteins metabolism, RNA, Messenger metabolism
- Abstract
The expression of connexin43, the primary gap-junction constituent of glial cells, was evaluated at the messenger RNA and protein levels in different grades of astrocytoma to investigate the relevance of gap junctions in herpes simplex virus-thymidine kinase (HSV-tk)-mediated gene therapy of brain tumors. Transduction of the retroviral-mediated HSV-tk gene into tumor cells with subsequent administration of ganciclovir has recently been used as an experimental therapeutic strategy for treatment of brain tumors. One aspect of this approach is the bystander effect, which augments the efficacy of this therapeutic approach. Glioblastoma cells with minimum levels of connexin43 protein were transfected with a connexin43 complementary DNA. These cells manifested a marked increase in the in vitro bystander effect, supporting the contention that the in vitro bystander effect is a consequence of metabolic cooperation between cells mediated by gap junctions. To assess relative levels of gap-junction protein expression in the relevant tumor type, we examined primary astrocytomas, primary astrocytoma cell cultures, and glioblastoma cell lines. Although most astrocytoma tumor samples expressed connexin43, they differed in the level of expression, with the greatest variation exhibited in high-grade astrocytomas. Primary glioblastoma cell cultures and established glioblastoma cell lines also displayed some variability in connexin43 levels. In aggregate, our results anticipate that glioblastomas will have a varied bystander effect during HSV-tk gene therapy depending on the level of connexin43 expression.
- Published
- 1996
- Full Text
- View/download PDF
25. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy.
- Author
-
Bi WL, Parysek LM, Warnick R, and Stambrook PJ
- Subjects
- Base Sequence, Cell Count, Cell Death, Cell Division drug effects, Culture Media, Conditioned, DNA Primers, Ganciclovir metabolism, Gap Junctions metabolism, Gene Transfer Techniques, Genetic Vectors, Humans, Molecular Sequence Data, Tumor Cells, Cultured, Cell Communication, Ganciclovir pharmacology, Genetic Therapy, Simplexvirus enzymology, Thymidine Kinase genetics
- Abstract
Tumor cells transduced with a retroviral vector expressing a herpes virus thymidine kinase (HSV tk) gene are rendered sensitive to the antiherpetic drug, ganciclovir. The bystander effect refers to the observation that not all cells need be transduced to eradicate the cell population by treatment with ganciclovir. We demonstrate that metabolic cooperation can account for this bystander effect. When HT1080 human fibrosarcoma cells marked with a lacZ gene (LZ+5) were cocultured with HT1080 cells transduced with a retrovirus expressing HSVtk (HT1080tk11), at a density at which the majority of cells were in contact, both HT1080tk11 and LZ+5 cells were killed by ganciclovir. When cells were cocultured at a low density where the majority of cells are not in contact with one another, however, only the HT1080tk11 cells were killed. This result suggests that cell contact with HT1080tk11 cells is necessary to render the HSVtk- LZ+5 cells sensitive to ganciclovir. Because involvement of metabolic cooperation in the killing of the LZ+5 cells would require not only contact between HT1080tk11 and LZ+5 cells but also the capacity to transfer small cytotoxic molecules from the former cell to the latter, transfer of radioactive molecules between the two cell lines was assessed by autoradiography after treatment of a coculture with [3H]ganciclovir. Isolated HT1080tk11 cells incorporated the labeled ganciclovir into their nuclei, whereas isolated LZ+5 cells did not. LZ+5 cells incorporated [3H]ganciclovir, only when in contact with HT1080tk11 cells. These findings indicate that a ganciclovir metabolic product, presumably a phosphorylated form, can pass from HSV tk+ to HSV tk- cells and mediate cytotoxicity as a consequence of direct contact.
- Published
- 1993
- Full Text
- View/download PDF
26. [Implantation of genetically modified endothelial cells. A new promising technique for gene therapy].
- Author
-
Bi WL and Tang J
- Subjects
- Endothelium cytology, Endothelium transplantation, Endothelium, Vascular cytology, Humans, Recombination, Genetic, Endothelium, Vascular transplantation, Genetic Therapy
- Published
- 1992
27. [Effect of endothelin on the release of angiotensin II from rat cardiovascular system].
- Author
-
Bi WL, Xie XZ, Wu JN, Xu BG, Zhao QY, Li ZP, Yu ZY, Tang J, and Tang CS
- Subjects
- Animals, Aorta cytology, Cells, Cultured, Heart Atria metabolism, Male, Muscle, Smooth, Vascular cytology, Rats, Angiotensin II metabolism, Aorta metabolism, Endothelins pharmacology, Muscle, Smooth, Vascular metabolism
- Abstract
The existence of angiotensin II immunoreactive substance in rat cardiovascular system was demonstrated by RIA and immunohistochemistry techniques. In atrium, aorta and cultured rat aorta smooth muscle cells, angiotensin II content is 7.2 + 2.7 pg/mg protein, 152.4 + 59.2 pg/mg protein and 3.5 + 0.8 pg/2 x 10(5) cells respectively. Endothelin, a potent vasoconstricting polypeptide, can enhance the release of angiotensin II from cultured rat aorta and aortic smooth muscle cells significantly. The results suggest that endothelin may be involved in the regulation of local blood flow and vascular tone, and it may also implicate the pathogenesis of some cardiovascular diseases such as cardiohypertrophy and vascular hypertrophy.
- Published
- 1990
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.